BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34980776)

  • 1. Directional Drug Transport through Membrane-Supported Monolayers of Human Liver-Derived Cell Lines.
    Mizoi K; Kobayashi M; Mashimo A; Matsumoto E; Masuda N; Itoh M; Ueno T; Tachiki H; Ishida S; Ogihara T
    Biol Pharm Bull; 2022; 45(1):150-153. PubMed ID: 34980776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Screening System for Biliary Excretion of Drugs Using Human Cholangiocyte Organoid Monolayers with Directional Drug Transport.
    Mizoi K; Okada R; Mashimo A; Masuda N; Itoh M; Ishida S; Yamazaki D; Ogihara T
    Biol Pharm Bull; 2024; 47(2):427-433. PubMed ID: 38369341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Hepatic and Intestinal Efflux Transport of Statins.
    Deng F; Tuomi SK; Neuvonen M; Hirvensalo P; Kulju S; Wenzel C; Oswald S; Filppula AM; Niemi M
    Drug Metab Dispos; 2021 Sep; 49(9):750-759. PubMed ID: 34162690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
    Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
    Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
    Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
    J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.
    Liu Y; Wang Y; Peng Y; Liu B; Ma F; Jiang J; Wang Q; Chang J
    Pharmazie; 2018 Sep; 73(9):503-507. PubMed ID: 30223932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance.
    Kwatra D; Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
    Int J Pharm; 2010 Aug; 395(1-2):114-21. PubMed ID: 20573570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A; Sabit H; Amidon GL
    AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Stereochemical Configuration on the Transport and Metabolism of Catechins from Green Tea across Caco-2 Monolayers.
    Ai Z; Liu S; Qu F; Zhang H; Chen Y; Ni D
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30917581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efflux transport of nicotine, cotinine and trans-3'-hydroxycotinine glucuronides by human hepatic transporters.
    Järvinen E; Sjöstedt N; Koenderink JB; Kidron H; Finel M
    Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):490-498. PubMed ID: 31237077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
    Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
    Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of human multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 2 (MRP2) in the transport of Huperzine A
    Fei Z; Hu M; Baum L; Kwan P; Hong T; Zhang C
    Xenobiotica; 2020 Mar; 50(3):354-362. PubMed ID: 31132291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin.
    Vadlapatla RK; Vadlapudi AD; Kwatra D; Pal D; Mitra AK
    Int J Pharm; 2011 Nov; 420(1):26-33. PubMed ID: 21864659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2.
    Marchetti S; Oostendorp RL; Pluim D; van Eijndhoven M; van Tellingen O; Schinkel AH; Versace R; Beijnen JH; Mazzanti R; Schellens JH
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3307-13. PubMed ID: 18089724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance-associated protein 2 (MRP2) is an efflux transporter of EGCG and its metabolites in the human small intestine.
    Kikuchi T; Hayashi A; Ikeda N; Morita O; Tasaki J
    J Nutr Biochem; 2022 Sep; 107():109071. PubMed ID: 35636688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines.
    Wang Z; Pal D; Patel A; Kwatra D; Mitra AK
    Int J Pharm; 2013 Jan; 441(1-2):40-9. PubMed ID: 23262422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells.
    Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC
    Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
    Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
    Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.